BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Drug Development

  Helsinn And MEI Pharma Report Correlation Between Mutations In DNA Methylation Pathway And Clinical Response In Phase II Study Of Pracinostat And Azacitidine In Acute Myeloid Leukemia

  June 5, 2017

   · 

  8 min read
• Primex Pharma At Euroanaesthesia 2017: Next Innovation In The Management Of Paediatric Sedation

  June 5, 2017

   · 

  2 min read
• Drug Development

  Daiichi Sankyo Release: New Precision Medicine Data On DS-8201 In HER2-Expressing Breast Cancer Revealed At 2017 ASCO Annual Meeting

  June 5, 2017

   · 

  7 min read
• Drug Development

  Janssen R&D Release: Data At ASCO Show Consistent Progression-Free Survival Benefit In Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Patients Treated With Ibrutinib, Including Those With High-Risk Disease, With Up To Four Yea

  June 5, 2017

   · 

  12 min read
• Drug Development

  Janssen R&D Release: Daratumumab Combination Therapy Improved Clinical Outcomes Regardless Of Cytogenetic Risk For Previously-Treated Patients With Multiple Myeloma

  June 5, 2017

   · 

  19 min read
• Policy

  Amgen Submits Regulatory Applications For Repatha (evolocumab) Cardiovascular Outcomes Data In U.S. And Europe

  June 5, 2017

   · 

  18 min read
• Business

  Guardant Health Announces Broad, Long-Term Alliance With Pfizer Oncology Supporting Multiple Clinical Programs With The Guardant360 Assay

  June 5, 2017

   · 

  2 min read
• Drug Development

  Positive Phase IIb Trial Of Pharmalink AB’s Nefecon In Primary IgA Nephropathy Presented At Leading Kidney Disease Conference

  June 5, 2017

   · 

  5 min read
• BioCad Registered The First Rituximab Biosimilar In Bolivia And Honduras

  June 5, 2017

   · 

  1 min read
• Drug Development

  AbbVie Release: New Data Presented At ASCO 2017 Finds IMBRUVICA (Ibrutinib) May Offer A More Targeted Approach To Chronic Lymphocytic Leukemia (CLL) Treatment Than Chemotherapy Agent Chlorambucil In Treatment-Naïve Patients

  June 5, 2017

   · 

  14 min read